MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Predictors of onset of psychosis in Parkinson’s disease: “Who gets it early?”

    P. Pal, A. Lenka, L. George, S. Arumugham, S. Hegde, N. Kamble, R. Yadav (Bangalore, India)

    Objective: To explore the factors which may predict the onset of psychosis in Parkinson’s disease (PD). Background: Non-motor symptoms (NMS) are commonly observed in PD.…
  • 2017 International Congress

    Which self-report motor experiences of daily living best predict objective motor function in patients with Parkinson’s disease?

    S. Anderson, J. Goldman, S. Luo, A. Negron, C. Goetz, G. Stebbins (Chicago, IL, USA)

    Objective: To identify the most important self-reported motor experience predictors of objective measures of motor impairment in patients with Parkinson's disease (PD). Background: The MDS-UPDRS has…
  • 2017 International Congress

    Motor and Body Composition Variables by Parkinson’s Disease Staging

    L. LEANDRO, C. MOREIRA, H. TEIVE (Curitiba, Brazil)

    Objective: Knowing the motor variables involved in the relationship of body composition and staging of disease. Background: Functional limitation, defined as a restriction in the…
  • 2017 International Congress

    Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson disease

    N. Lakkappa, P. Thaggikuppe Krishnamurthy, P.D. Mirazkar, N. Lakkappa, P. Krishnamurthy, P.M.D., M.M. Srinivas Bharath, B. Hammock, S.H. Hwang (Udhagamandalam, India)

    Objective: To evaluate the potential anti-parkinson activity of PTUPB (4-(5-phenyl-3-{3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl}-pyrazol-1-yl)-benzenesulfonamide) a dual inhibitor of soluble Epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2) against rotenone induced mitochondrial dysfunction,…
  • 2017 International Congress

    Nilotinib differentially affects oligomeric α-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson’s disease with dementia and Lewy body dementia

    F. Pagan, M. Hebron, Y. Torres-Yaghi, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, A. Shekoyan, J. Ahn, C. Moussa (Washington, DC, USA)

    Objective: This is a retrospective biomarker study of an open-label clinical study to examine the safety and efficacy of lower doses (<50% of CML dose)…
  • 2017 International Congress

    Deep Learning in Objective Classification of Spontaneous Movement of Patients with Parkinson’s Disease Using Large-Scale Free-Living Sensor Data

    F. Pfister, D. Kulić, T. Um, D. Pichler, A. Ahmadi, M. Lang, G. König, F. Achilles, S. Endo, K. Abedinpour, K. Ziegler, K. Bötzel, S. Hirche, A. Ceballos-Baumann, U. Fietzek (Munich, Germany)

    Objective: Our goal was to classify spontaneous movement using a commercially available motion sensor in a clinically meaningful 3-/9-step discrete scale (SMS-3/SMS-9). Background: Brady-hypokinetic and dyskinetic…
  • 2017 International Congress

    Tandem Standing

    E. Okuyucu, E. Dogru Huzmeli, S. Colakoglu Yesildag, I. Huzmeli (Hatay, Turkey)

    Objective: The aim of this study is to learn, patients who can’t make tandem standing fall more or not? Background: Falls occur more often with…
  • 2017 International Congress

    A Preliminary Study: Validity and Reliability of Parkinson Fatigue Scale (PFS) in Turkish Patients with Parkinson’s Disease (PD)

    E. Ozturk, E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)

    Objective: The purpose of this study was to investigate the validity and reliability of the Turkish version of PFS. Background: The PFS is a 16-item…
  • 2017 International Congress

    Functional Connectivity Differences Across Parkinson Disease Subtypes

    M. Campbell, C. Gratton, J. Koller, W. Shannon, C. Lessov-Schlaggar, S. Petersen, J. Perlmutter (St. Louis, MO, USA)

    Objective: The goals of this project were to 1) identify putative Parkinson disease (PD) clinical subtypes and 2) investigate resting-state functional connectivity differences between these…
  • 2017 International Congress

    Multicenter Validation of Disease- related Parkinson’s disease pattern with Resting State functional MRI

    K. Schindlbeck, A. Vo, Y. Ma, S. Peng, K. Poston, H. Hurtig, N. Dahodwala, D. Eidelberg (Manhasset, NY, USA)

    Objective: To validate Parkinson’s Disease-related network topography characterized with resting-state functional MRI (rs-fMRI) in two multicenter based cohorts of idiopathic Parkinson’s disease (IPD) patients.  Background:…
  • « Previous Page
  • 1
  • …
  • 296
  • 297
  • 298
  • 299
  • 300
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley